These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11708132)

  • 1. Crystal structure and synthesis of 17 alpha-(5-bromovaleroyloxy)-16 beta-methylpregna-4,6-diene-3,20-dione.
    Soriano-García M; Ramírez E; Bratoeff E; Cabeza M; Aguirre-Hernández G
    Anal Sci; 2001 Jul; 17(7):911-2. PubMed ID: 11708132
    [No Abstract]   [Full Text] [Related]  

  • 2. Crystal structure and synthesis of 17 alpha-acetoxy-4-bromopregn-4-ene-3,20-dione.
    Soriano-García M; Ramírez E; Bratoeff E; Cabeza M; Aguirre-Hernández G
    Anal Sci; 2002 Aug; 18(8):963-4. PubMed ID: 12200852
    [No Abstract]   [Full Text] [Related]  

  • 3. Crystal structure and synthesis of 17alpha-hexanoyloxy-16beta-methylpregna-4,6-diene-3,20-dione.
    Soriano-García M; Ramírez E; Bratoeff E; Cabeza M; Aguirre-Hernández G
    Anal Sci; 2001 Oct; 17(10):1245-6. PubMed ID: 11990608
    [No Abstract]   [Full Text] [Related]  

  • 4. Crystal structure and synthesis of 17alpha-(5-chlorovaleroyloxy)-16beta-methylpregna-4,6-diene-3,20-dione.
    Soriano-García M; Ramírez E; Bratoeff E; Cabeza M; Aguirre-Hernández G
    Anal Sci; 2003 Apr; 19(4):639-40. PubMed ID: 12725409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First synthesis of separable isomeric testosterone dimers showing differential activities on prostate cancer cells.
    Bastien D; Leblanc V; Asselin E; Bérubé G
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2078-81. PubMed ID: 20226660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiandrogen. III. 11-oxapregnane steroids.
    Takegawa S; Koizumi N; Mieda M; Shibata K
    Chem Pharm Bull (Tokyo); 1996 Apr; 44(4):746-8. PubMed ID: 8681406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens: synthesis, in vitro biological activity, pharmacokinetics, and antitumor activity in the LAPC4 human prostate cancer xenograft model.
    Handratta VD; Vasaitis TS; Njar VC; Gediya LK; Kataria R; Chopra P; Newman D; Farquhar R; Guo Z; Qiu Y; Brodie AM
    J Med Chem; 2005 Apr; 48(8):2972-84. PubMed ID: 15828836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unexpected binding orientation of bulky-B-ring anti-androgens and implications for future drug targets.
    Duke CB; Jones A; Bohl CE; Dalton JT; Miller DD
    J Med Chem; 2011 Jun; 54(11):3973-6. PubMed ID: 21506597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and structure-activity relationships of the first ferrocenyl-aryl-hydantoin derivatives of the nonsteroidal antiandrogen nilutamide.
    Payen O; Top S; Vessières A; Brulé E; Plamont MA; McGlinchey MJ; Müller-Bunz H; Jaouen G
    J Med Chem; 2008 Mar; 51(6):1791-9. PubMed ID: 18303829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in the chemistry and pharmacological activity of new steroidal antiandrogens and 5 alpha-reductase inhibitors.
    Bratoeff E; Cabeza M; Ramirez E; Heuze Y; Flores E
    Curr Med Chem; 2005; 12(8):927-43. PubMed ID: 15853706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of androgen receptor full antagonists bearing a p-carborane cage: promising ligands for anti-androgen withdrawal syndrome.
    Goto T; Ohta K; Fujii S; Ohta S; Endo Y
    J Med Chem; 2010 Jul; 53(13):4917-26. PubMed ID: 20521823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a benzopyran-containing androgen receptor antagonist to treat antiandrogen-resistant prostate cancer.
    Oh S; Nam HJ; Park J; Beak SH; Park SB
    ChemMedChem; 2010 Apr; 5(4):529-33. PubMed ID: 20135667
    [No Abstract]   [Full Text] [Related]  

  • 13. Novel 17-azolyl steroids, potent inhibitors of human cytochrome 17 alpha-hydroxylase-C17,20-lyase (P450(17) alpha): potential agents for the treatment of prostate cancer.
    Njar VC; Kato K; Nnane IP; Grigoryev DN; Long BJ; Brodie AM
    J Med Chem; 1998 Mar; 41(6):902-12. PubMed ID: 9526564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two androsterone derivatives as inhibitors of androgen biosynthesis.
    Djigoue GB; Simard M; Kenmogne LC; Poirier D
    Acta Crystallogr C; 2012 Jun; 68(Pt 6):o231-4. PubMed ID: 22669194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of androgen receptor antagonists with bulky side chains for overcoming antiandrogen resistance.
    Zhou J; Geng G; Shi Q; Sauriol F; Wu JH
    J Med Chem; 2009 Sep; 52(17):5546-50. PubMed ID: 19725582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgens and pharmacology.
    Haendler B
    Andrologia; 2005 Dec; 37(6):213-5. PubMed ID: 16336252
    [No Abstract]   [Full Text] [Related]  

  • 17. 4-(Anilino)pyrrole-2-carboxamides: Novel non-steroidal/non-anilide type androgen antagonists effective upon human prostate tumor LNCaP cells with mutated nuclear androgen receptor.
    Wakabayashi K; Imai K; Miyachi H; Hashimoto Y; Tanatani A
    Bioorg Med Chem; 2008 Jul; 16(14):6799-812. PubMed ID: 18571420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor agents. 217. Curcumin analogues as novel androgen receptor antagonists with potential as anti-prostate cancer agents.
    Ohtsu H; Xiao Z; Ishida J; Nagai M; Wang HK; Itokawa H; Su CY; Shih C; Chiang T; Chang E; Lee Y; Tsai MY; Chang C; Lee KH
    J Med Chem; 2002 Nov; 45(23):5037-42. PubMed ID: 12408714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of p450 17 as a new strategy for the treatment of prostate cancer.
    Leroux F
    Curr Med Chem; 2005; 12(14):1623-9. PubMed ID: 16022662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3 beta-acetoxyandrost-1,5-diene-17-ethylene ketal functions as a potent antiandrogen with marginal agonist activity.
    Miyamoto H; Marwah P; Marwah A; Lardy H; Chang C
    Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4440-4. PubMed ID: 12672951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.